Target intelligence / Profile preview

Pulmonary vasculature

Molecular classification
Other
01

Overview

The pulmonary vasculature is the specialized system of blood vessels that facilitates gas exchange by carrying deoxygenated blood from the right ventricle to the lungs and returning oxygenated blood to the left atrium. It comprises the pulmonary arteries, a dense capillary network, and pulmonary veins, characterized by a high-flow, low-pressure environment under normal physiological conditions (StatPearls, 2023). Pathological changes in this system, such as endothelial dysfunction, smooth muscle cell proliferation, and plexiform lesion formation, are hallmarks of pulmonary arterial hypertension (PAH) and other vascular lung diseases (Circulation Research, 2014). While the pulmonary vasculature itself is an anatomical structure rather than a single molecular target, it serves as the site for various therapeutic interventions. Drugs like phosphodiesterase-5 inhibitors, endothelin receptor antagonists, and prostacyclin analogues target specific molecular pathways within these vessels to alleviate vasoconstriction and structural remodeling (Journal of the American College of Cardiology, 2013).

Other names
Pulmonary circulationLung blood vesselsPulmonary vascular bed
02

Mechanism of action

Drugs targeting components of the pulmonary vasculature typically act through vasodilation, inhibition of vascular remodeling, and reduction of pulmonary vascular resistance.

03

Biological functions

Gas exchangeBlood pressure regulationBlood filtrationAcid-base balance
04

Disease associations

Pulmonary arterial hypertensionPulmonary embolismChronic thromboembolic pulmonary hypertensionPulmonary edemaAcute respiratory distress syndrome
05

Safety considerations

Systemic hypotensionPeripheral edemaHeadacheFlushingSyncope
06

Interacting drugs

Sildenafil

6 more in the full profile.

07

Biomarkers

Mean pulmonary arterial pressure (mPAP)Pulmonary vascular resistance (PVR)Brain natriuretic peptide (BNP)N-terminal pro-b-type natriuretic peptide (NT-proBNP)

Beyond the preview

Go deeper on Pulmonary vasculature.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmonary vasculature.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call